DOD Biotech Public , Ltd. Profit Margin

As of the most recent data (June 2026), DOD.BK shows a profit margin of 0.35%. That compares with 7.51% in the prior-year period — down 95.3% year over year. That is below the sector sector average of 13.2%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DOD.BK's profit margin is now 0.35% (was 7.51%) — a 95.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether DOD Biotech Public , Ltd. is outperforming or lagging.

The its sector sector average profit margin is about 13.2%. DOD Biotech Public , Ltd. is at 0.35%, which is lower that average. That is roughly 97.3% below the sector mean. Use the comparison chart on this page to see how DOD.BK stacks up against individual peers as well.

That compares with 7.51% in the prior-year period — down 95.3% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare DOD Biotech Public , Ltd. with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has DOD Biotech Public , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 0.35%) with ownership activity and broader fundamentals.